It was just two years ago that we marked the untimely passing of Tania Douglas, co-founder and board member of CapeRay, following […]
It was just two years ago that we marked the untimely passing of Tania Douglas, co-founder and board member of CapeRay, following […]
Digital breast tomosynthesis (DBT) was approved by the FDA in 2011 as a screening modality for the early detection of […]
Fifteen years ago, when CapeRay was still being incubated within the University of Cape Town (UCT), we were awarded a […]
Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]
If we cast our minds back to November 1895, to Würzburg in Germany, we can see the physicist Wilhelm Röntgen […]
We are all familiar with the expression, “killing two birds with one stone,” which means to achieve two things by […]
The National Institutes of Health (NIH) has its origins in a one-room laboratory in New York City in 1887 and […]
The European Journal of Radiology has just published a paper by two Boston radiologists, Michael Fishman and Madan Rehani, entitled “Monochromatic X-rays: […]
Four years ago, we contributed a blog entitled “From land mines to breast cancer” in which we described a system from UK […]
The June issue of Diagnostic Imaging Europe was published earlier this week and featured numerous articles on breast imaging. The magazine, […]